These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6186223)

  • 1. [Pre- and postoperative reactivity of breast cancer patients to tumor associated antigens and HEP in the macrophage electrophoresis mobility (MEM) test].
    Ladusch M; Schäffner H; Ullmann L; Littmann M; Reimann S; Gindl P; Ambrosius H
    Arch Geschwulstforsch; 1982; 52(6):469-78. PubMed ID: 6186223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactivity in the MEM-test of cancer patients' lymphocytes incubated with brain-derived preparations and extracts from malignant teratomas.
    Müller M; Irmscher J; Grossmann H; Kotzsch M; Wagner H; Kemmer C
    Arch Geschwulstforsch; 1981; 51(4):354-63. PubMed ID: 6172087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies with the macrophage migration inhibition (MMI) test in patients with malignant disease.
    Light PA; Preece AW; Waldron HA
    Clin Exp Immunol; 1975 Nov; 22(2):279-84. PubMed ID: 55328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The macrophage electrophoretic mobility (MEM) test for malignant disease. Further clinical investigations and studies on macrophage slowing factors.
    Preece AW; Light PA
    Clin Exp Immunol; 1974 Dec; 18(4):543-52. PubMed ID: 4143199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage migration inhibition factor test in breast tumors.
    Gutman H; Kott I; Rabinerson D; Reiss R
    Isr J Med Sci; 1986 Nov; 22(11):812-6. PubMed ID: 3793437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Reaction of inhibition of macrophage electrophoretic mobility in differential diagnosis of carcinomas].
    Miuller M; Irmsher Iu; Fisher R; Grosmann G
    Vopr Onkol; 1976; 22(12):43-50. PubMed ID: 1020256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Checking of carcinoma patients with the leukocyte migration technique (LMT) under agarose.
    Emmrich F; Ambrosius H
    Neoplasma; 1978; 25(4):483-91. PubMed ID: 80756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage electrophoretic mobility (MEM) test in cancer: a critical evaluation.
    Field EJ; Caspary EA; Smith KS
    Br J Cancer Suppl; 1973 Aug; 1():208-14. PubMed ID: 4140728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactivity of serum-armed xenogeneic macrophages to breast cancer antigens.
    Harris LF; Miller LL; Hickok DF
    Cancer Res; 1982 Dec; 42(12):4985-90. PubMed ID: 7139603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro reaction of lymph node cells of mice to protein and cell-bound antigens. A study with the macrophage electrophoretic mobility test ].
    Schäffner H
    Allerg Immunol (Leipz); 1981; 27(3):145-52. PubMed ID: 6181671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KCl carcinoma extracts as tumor antigens in the electrophoretic mobility test: clinical evaluation.
    Muhrer KH; Link KH
    Cancer Detect Prev; 1983; 6(1-2):101-6. PubMed ID: 6883371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cross-reactivity of 3M KCl-extracts of fetal tissue from various species in the macrophage electrophoresis mobility test. II. Tissue extracts from lower vertebrates in various phases of development].
    Schlott B; Gryschek G; Schubert E; Pasternak G
    Arch Geschwulstforsch; 1983; 53(5):401-6. PubMed ID: 6606408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral leukocyte migration inhibition reactivity to breast cancer antigens in patients with breast cancer and in normal controls.
    Brandes LJ; Goldenberg GJ
    Cancer Res; 1976 Oct; 36(10):3707-10. PubMed ID: 953996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunologic localization of primary tumors].
    Muhrer KH; Filler D; Pasurka B
    Chirurg; 1982 Apr; 53(4):258-62. PubMed ID: 7083967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The macrophage electrophoretic mobility assay in patients with renal cell carcinoma.
    Malkovský M; Bubeník J; Jakoubková J; Suhajová E; Indrová M; Jandlová T; Símová J
    Neoplasma; 1981; 28(2):245-51. PubMed ID: 7254439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of tumor-infiltrating antigen presenting cells by high intensity focused ultrasound ablation of human breast cancer.
    Xu ZL; Zhu XQ; Lu P; Zhou Q; Zhang J; Wu F
    Ultrasound Med Biol; 2009 Jan; 35(1):50-7. PubMed ID: 18950932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary characterization of a colon tumour tissue preparation used in macrophage electrophoretic mobility (MEM) test1.
    Grossmann H; Müller M; Heidl G; Irmscher J; Kotzsch M; Wagner H
    Arch Geschwulstforsch; 1981; 51(4):310-6. PubMed ID: 7032449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experiences with the macrophage adherence inhibition test within the framework of preparing tumor-associated antigens from human breast cancers].
    Bendix U; Bendix U
    Allerg Immunol (Leipz); 1985; 31(4):273-82. PubMed ID: 2936220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Improvement of specificity and reactivity of the leukocyte migration test for the diagnosis and follow-up care in stomach cancer].
    Schulz U; Zoeller M; Matzku S
    Chir Forum Exp Klin Forsch; 1977 Apr; ():63-8. PubMed ID: 618315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactivity of human lymphocytes to teratoma preparations as revealed by the macrophage electrophoretic mobility (MEM) technique.
    Irmscher J; Grossmann H; Kotzsch M; Wagner H; Müller M
    Arch Geschwulstforsch; 1982; 52(5):349-53. PubMed ID: 7149908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.